ArticleMolecular and clinical oncology2025
Comparison of enteral nutrition methods with weight improvement in patients with T4b esophageal squamous cell carcinoma.
Article in Molecular and clinical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enteral nutrition is the preferred method for providing nutrition to patients who can consume food orally or via a feeding tube. In the case of patients with advanced esophageal cancer, tracking nutritional status is critical and weight is a key factor in this regard. Monitoring weight changes is a simple and non-invasive approach that can be easily incorporated into clinical settings. Therefore, the present study aimed to compare different enteral nutrition techniques and assess the efficacy of weight changes in patients with advanced esophageal cancer. A retrospective study was conducted on patients with advanced esophageal squamous cell carcinoma who received enteral nutrition between January 2012 and December 2022, and included the collection of various data, including baseline characteristics, comorbidities, BMI, route of enteral nutrition, tolerable enteral nutrition, total calories per day and mode of treatment via methods such as nasogastric tube (NG), esophageal stent, percutaneous endoscopic gastrostomy (PEG) or open gastrostomy (OG). The study assessed the impact of enteral nutrition on body weight at the 0-, 1-, 3- and 6-month follow-up, as well as the 1-year survival. After a 3-month follow-up, it was observed that patients with advanced esophageal cancer who underwent enteral nutrition exhibited a significant improvement in weight. This improvement trended to be sustained up to the 6-month follow-up. At 3 months, the groups that underwent NG, OG and PEG exhibited significant optimal results compared with the esophageal stent group (P=0.027, P=0.009 and P=0.001, respectively). No significant differences were observed among the NG, OG and PEG methods. The enteral nutrition can aid in weight improvement for patients who suffer from advanced esophageal cancer. Enteral feeding tubes have been demonstrated to be safe and effective options. Within 3 months of beginning nutrition support, there was a trend of weight improvement, which could be maintained up to the 6-month follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.